(VIANEWS) – The Market ended the session with SEQUANA MEDICAL (SEQUA.BR) rising 20.97% to €0.75 on Wednesday, following the last session’s downward trend. BEL 20 dropped 0.38% to €4,311.09, following the last session’s upward trend on what was a somewhat negative trend trading session today.
SEQUANA MEDICAL’s last close was €0.62, 87.22% below its 52-week high of €4.85.
About SEQUANA MEDICAL
Sequana Medical NV develops and commercializes treatments for patients with diuretic-resistant fluid overload in liver disease, cancer, and heart failure in Belgium, Germany, France, Switzerland, and internationally. The company products pipeline comprises alfapump system, an implantable pump system for the treatment of refractory liver ascites and malignant ascites; and Direct Sodium Removal (DSR) for the treatment of fluid overload spread across the body and heart failure. Sequana Medical NV was founded in 2006 and is headquartered in Ghent, Belgium.
Earnings Per Share
As for profitability, SEQUANA MEDICAL has a trailing twelve months EPS of €-1.22.
More news about SEQUANA MEDICAL (SEQUA.BR).
